Filing Details

Accession Number:
0000899243-19-025909
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-24 18:36:30
Reporting Period:
2019-10-22
Accepted Time:
2019-10-24 18:36:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750019 Tcr2 Therapeutics Inc. TCRR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575745 Morana Jovan-Embiricos C/O Lj Fiduciary, 8, Rue Saint-Leger
Geneva V8 CH-1205
No No Yes No
1600769 Ltd Holdings Globeways 3Rd Floor, Geneve Place, Waterfront Dr
Po Box 3175, Road Town, Tortola, Bvi
Ch-1205 Geneva V8
No No Yes No
1767390 Ltd 2017 I Captial F2 C/O Lj Fiduciary, 8, Rue Saint-Leger
Geneva V8 CH-1205
No No Yes No
1767391 Ltd 2015 I Capital F2 C/O Lj Fiduciary, 8, Rue Saint-Leger
Geneva V8 CH-1205
No No Yes No
1767396 Ltd Mg F2 C/O Lj Fiduciary, 8, Rue Saint-Leger
Geneva V8 CH-1205
No No Yes No
1767397 F2 - Tpo Investments Llc C/O Singer Mckeon, 8 West 38Th Street,
Suite 1001
New York NY 10018
No No Yes No
1768161 Ltd Ii Holdings Globeways 3Rd Floor, Geneve Place, Waterfront Dr
Po Box 3175, Road Town, Tortola, Bvi
Geneva V8 CH-1205
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-22 580 $15.16 392,185 No 4 S Indirect By Fund
Common Stock Disposition 2019-10-22 693 $15.16 392,185 No 4 S Indirect By Fund
Common Stock Disposition 2019-10-22 530 $15.16 358,103 No 4 S Indirect By Fund
Common Stock Disposition 2019-10-22 2,085 $15.16 1,409,571 No 4 S Indirect By Fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
No 4 S Indirect By Fund
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,409,571 Indirect By Fund
Common Stock 90,026 Indirect By Fund
Common Stock 193,742 Indirect By Fund
Footnotes
  1. The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  2. The reported securities are owned directly by F2-TPO Investments, LLC. Globeways Holdings II Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  3. The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  4. The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  5. The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  6. The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  7. The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.